Literature DB >> 18198003

Seroprevalence of parvovirus B19 in the German population.

C Röhrer1, B Gärtner, A Sauerbrei, S Böhm, B Hottenträger, U Raab, W Thierfelder, P Wutzler, S Modrow.   

Abstract

Acute parvovirus B19 infection is a risk for pregnant women. After vertical transmission the infected fetus may develop hydrops fetalis. Since B19 infection occurs mainly during childhood, children represent a main source for virus transmission. In order to determine whether certain groups in the German population show increased risks for B19 infection we analysed the seroprevalence using 6583 sera collected from adults in former Eastern and Western Germany during the German National Health Survey and 649 sera from healthy Thuringian children and adolescents. In adults the overall seroprevalence was 72.1%, rising from 20.4% in children (1-3 years) and 66.9% in adolescents (18-19 years) to 79.1% in the elderly (65-69 years). Significant differences were observed between females (73.3%) and males (70.9%) and between inhabitants of small (74.8%) and big cities (69.0%) but not between people of the former Eastern (72.8%) and Western states (72.0%) of Germany. For women during childbearing age (18-49 years) highest values were observed in those living together with two or more children (81.6%) and in women with occupational contact with children aged <6 years (88.9%). In contrast seroprevalence was significantly lower in age-matched female singles (64.8%) and in women with occupational contact with children aged >6 years and adolescents (63.8%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18198003      PMCID: PMC2870752          DOI: 10.1017/S0950268807009958

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  32 in total

1.  Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians.

Authors:  J F Rodis; A F Borgida; M Wilson; J F Egan; M V Leo; A O Odibo; W A Campbell
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

2.  The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis.

Authors:  N Yaegashi; T Niinuma; H Chisaka; T Watanabe; S Uehara; K Okamura; S Moffatt; K Sugamura; A Yajima
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

3.  The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world.

Authors:  H A Kelly; D Siebert; R Hammond; J Leydon; P Kiely; W Maskill
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

Review 4.  Parvovirus B19 infection and its significance in pregnancy.

Authors:  G L Gilbert
Journal:  Commun Dis Intell       Date:  2000-03

5.  Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission.

Authors:  M Letaïef; G Vanham; K Boukef; S Yacoub; L Muylle; G Mertens
Journal:  Transfus Sci       Date:  1997-12

6.  Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

Authors:  W Thierfelder; W Hellenbrand; H Meisel; E Schreier; R Dortschy
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Immediate and long term outcome of human parvovirus B19 infection in pregnancy.

Authors:  E Miller; C K Fairley; B J Cohen; C Seng
Journal:  Br J Obstet Gynaecol       Date:  1998-02

8.  Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia.

Authors:  J Ø Odland; I V Sergejeva; M D Ivaneev; I P Jensen; B Stray-Pedersen
Journal:  Acta Obstet Gynecol Scand       Date:  2001-11       Impact factor: 3.636

Review 9.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.

Authors:  Martin Enders; Andrea Weidner; Iris Zoellner; Karen Searle; Gisela Enders
Journal:  Prenat Diagn       Date:  2004-07       Impact factor: 3.050

View more
  36 in total

1.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

2.  Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate.

Authors:  Peter Gowland; Stefano Fontana; Martin Stolz; Nicola Andina; Christoph Niederhauser
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

Review 3.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

4.  Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India.

Authors:  Rajlakshmi Viswanathan; Babasaheb V Tandale; Manisha S Tamayachekar; Santoshkumar M Jadhav; Kirtee A Khutwad; Kiran R Munne
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

5.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

Review 6.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  Republished: pathogenesis and diagnosis of myocarditis.

Authors:  Chantal Elamm; Delisa Fairweather; Leslie T Cooper
Journal:  Postgrad Med J       Date:  2012-09       Impact factor: 2.401

8.  High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.

Authors:  Colin P Sharp; Alice Lail; Sharyne Donfield; Ruth Simmons; Clifford Leen; Paul Klenerman; Eric Delwart; Edward D Gomperts; Peter Simmonds
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

9.  Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections.

Authors:  Päivi Norja; Anna Maria Eis-Hübinger; Maria Söderlund-Venermo; Klaus Hedman; Peter Simmonds
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

10.  Persistent adeno-associated virus 2 and parvovirus B19 sequences in post-mortem human cerebellum.

Authors:  James K Grant; Natalie C Yin; Annette M Zaytoun; Hena Waseem; Jacqueline A Hobbs
Journal:  Cerebellum       Date:  2009-07-08       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.